Literature DB >> 11752219

Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells.

Stuart D Shumway1, Craig M Berchtold, Michael N Gould, Shigeki Miyamoto.   

Abstract

Immature B cells express constitutive nuclear factor-kappaB (NF-kappaB) activity and inhibition of this activity is associated with the induction of apoptotic cell death. Previous studies have implicated a calcium-dependent proteolysis of the NF-kappaB inhibitory protein IkappaBalpha as critical in the maintenance of constitutive NF-kappaB activity in these cells. We tested whether modulation of diverse calcium-dependent processes affects the maintenance of constitutive NF-kappaB activity in the WEHI-231 immature B cell line. Calmodulin inhibitors, but not calcineurin inhibition, blocked both IkappaBalpha turnover and the maintenance of constitutive NF-kappaB activity. Inhibition of NF-kappaB DNA binding activity by the calmodulin antagonist W13 also resulted in a loss of the expression of the NF-kappaB target gene, IkappaBalpha. However, prolonged inhibition of NF-kappaB activity for up to 8 h did not lead to apoptotic induction in the WEHI-231 cells. Moreover, removal of calmodulin inhibitors resulted in the reappearance of constitutive NF-kappaB activity and the renewed expression of the IkappaBalpha gene. Thus, calmodulin activity is a requirement for the continual turnover of IkappaBalpha and the maintenance of constitutive NF-kappaB function in WEHI-231 cells. In addition, our findings suggest that inhibition of NF-kappaB activity does not lead to the immediate onset of apoptosis, indicating that prolonged inhibition of NF-kappaB-dependent gene expression is required to cause apoptosis of WEHI-231 B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752219     DOI: 10.1124/mol.61.1.177

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Role of β-TrCP ubiquitin ligase receptor in UVB mediated responses in skin.

Authors:  Neehar Bhatia; Tara A Demmer; Alok K Sharma; Irina Elcheva; Vladimir S Spiegelman
Journal:  Arch Biochem Biophys       Date:  2010-12-25       Impact factor: 4.013

Review 3.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

4.  A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.

Authors:  Stuart D Shumway; Shigeki Miyamoto
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

5.  Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.

Authors:  David T Yang; Ken H Young; Brad S Kahl; Stephanie Markovina; Shigeki Miyamoto
Journal:  Mol Cancer       Date:  2008-05-19       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.